hemotune Applauded by Frost & Sullivan for Enabling Selective and Efficient Extraction of Large Compounds from Blood With Its Blood Purification Platform
SAN ANTONIO, Oct. 27, 2022 /PRNewswire/ -- Recently, Frost & Sullivan assessed the blood purification technology industry and, based on its findings, recognizes hemotune with the 2022 Europe Technology Innovation Leadership Award. The company developed a therapeutic blood purification platform to improve health outcomes and save patients' lives. The innovative medical device company provides ground-breaking blood purification technology based on magnetic beads, which uniquely removes large biomolecule targets with extremely high selectivity and efficiency. The system will be first used to treat sepsis, a severe life-threatening condition linked to 20% of all deaths and rising healthcare costs according to hemotune. Its solution focuses on the immunological aspects of sepsis, tackling multiple disease pathways while restoring immune balance.
- SAN ANTONIO, Oct. 27, 2022 /PRNewswire/ --Recently, Frost & Sullivan assessed the blood purification technology industry and, based on its findings, recognizes hemotune with the 2022 Europe Technology Innovation Leadership Award.
- The company developed a therapeutic blood purification platform to improve health outcomes and save patients' lives.
- The innovative medical device company provides ground-breaking blood purification technology based on magnetic beads, which uniquely removes large biomolecule targets with extremely high selectivity and efficiency.
- With its strong overall performance, hemotune earns Frost & Sullivan's 2022 Europe Technology Innovation Leadership Award in the blood purification technology market.